# SEG Phase 7.8.8 — Legacy Identity Bridge Gate Report

## Final status

`BLOCKED_PENDING_IDENTITY_EVIDENCE`

## Evidence basis

| Measure | Result |
|---|---:|
| Legacy objects analyzed in completed Phase 7.8.7 | 1,919 |
| SEG staging candidates | 48 |
| `MATCHED` | 0 |
| `PROBABLE_MATCH` | 0 |
| `NO_MATCH` | 1,919 |
| `CONFLICT` | 0 |
| Bridge rows created in this phase | 0 |

## Gate decision

A deterministic identity bridge **cannot be created from existing evidence**. The existing evidence supports an isolated bridge design and fail-closed mapping rules, but it does not provide a shared identity namespace or an authorized unique relation from any legacy object to any SEG candidate.

| Gate | Status | Evidence-based finding |
|---|---|---|
| Legacy namespace preservation | `PASS` | Legacy asset/object IDs and observed fields can be preserved exactly. |
| SEG staging identity preservation | `PASS` | Candidate ID, source ID, target type, path, SHA, duplicate lineage, and observed review/rights/closure states are available. |
| Explicit legacy-to-SEG join | `BLOCKED` | No shared explicit join key; 0/1,919 linked. |
| Exact title join | `BLOCKED` | Candidate inventory does not provide a complete legacy-comparable title key, and legacy title coverage is incomplete. |
| Topic/family join | `BLOCKED` | Topic/family relationships are contextual and lack an authorized unique mapping contract. |
| Reference/chapter join | `BLOCKED` | No explicit source/version/locator relation to a unique candidate is supplied. |
| Bridge review state | `BLOCKED` | No identity review was performed or assigned by this design. |
| Downstream clinical/rights/implementation gates | `OPEN` | Remain separate; this identity design does not close them. |

## Minimum evidence needed to unblock identity design

1. A versioned authoritative cross-reference with one row per intended legacy object, including `legacy_source`, exact `legacy_object_id`, `legacy_object_type`, and either one exact `target_candidate_id`/`source_id` or an explicit `NO_LINK` disposition.
2. If the cross-reference is derived from titles/topics/chapters/references instead of IDs, an approved deterministic contract must define exact comparison fields, uniqueness, collision handling, source/version/locator requirements, and conflict escalation.
3. A designated identity reviewer role and review record format must be supplied. This is separate from clinical review, rights review, and Medical Owner approval.
4. Duplicate families must have explicit lineage handling for `DUP-DRUG-001` and `DUP-EMERGENCY-001`, with no merge, deletion, overwrite, or silent primary selection.

## Why the next status is not ready

`READY_FOR_PHASE_7_9_ADAPTER_DESIGN` is not supported because the adapter target cannot yet be populated with traceable legacy-to-candidate relations. Designing an adapter around guessed joins would violate source preservation, lineage, and fail-closed integration requirements.

## Next allowed phase

The next allowed action is **identity evidence closure / controlled bridge review**, not adapter execution. After explicit identity evidence is supplied and reviewed, a separate Phase 7.9 adapter-design review may reassess readiness. No import authorization is implied.

## Non-actions verified

| Action | Result |
|---|---|
| Production JSON generation | `false` |
| Content transformation or rewriting | `false` |
| Schema replacement/modification | `false` |
| Database write/import/migration | `false` |
| Adapter execution | `false` |
| Activation/publication/learner exposure | `false` |
| Clinical or rights approval | `false` |
